Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia

PHASE3CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

August 31, 2000

Study Completion Date

February 28, 2003

Conditions
Hyponatremia
Interventions
DRUG

YM087

Trial Locations (47)

Unknown

Mobile

Phoenix

Tuscon

La Jolla

Los Angeles

Santa Rosa

Miami

Plantation

Springfield

Indianapolis

Shreveport

Worchester

Petoskey

Minneapolis

Rolla

St Louis

Omaha

New York

Cleveland

Oklahoma City

Columbia

Sioux Falls

Chattanooga

Norfolk

Salem

Huntington

Madison

Drummondville

Montreal 2 Sites

Ashkelon

Beersheba

Haifa 2 Sites

Holon

Jerusalem

Rehovot

Safed

Tel Aviv

Tel Litwinsky

Bloemfontein

Buff

Durban

East London

eManzimtoti

Johannesburg

Lyttelton Manor

Port Elizabeth

Pretoria

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma US, Inc.

INDUSTRY

lead

Cumberland Pharmaceuticals

INDUSTRY